No Data
No Data
bj health (02389.HK) achieved HKD 7330.7 million in revenue in the first half of the year.
On August 29, Glemei announced its interim performance. In the first half of 2024, the company's revenue was 7,330.7 Hong Kong dollars, a decrease of 6.06% year-on-year. The company's shareholders' attributable loss for the period was 56.411 million Hong Kong dollars, with a basic loss per share of 0.93 Hong Kong cents.
BJ HEALTH: ANNOUNCEMENT OF THE INTERIM RESULTSFOR THE PERIOD ENDED 30 JUNE 2024
bj health (02389.HK) expects to increase its mid-term losses.
On August 9th, Gelunhui reported that BJ Health (02389.HK) expected its attributable loss for the period ending June 30, 2024 to increase by approximately HKD 40 million compared to the same period in 2023. During this period, the group's daily business operations remained relatively stable. The main reasons for the increase in attributable loss were: (1) due to the depreciation of the Canadian dollar, the group's other receivables and investments in associated companies denominated in Canadian dollars recorded a forex loss of approximately HKD 12.4 million, while a forex gain of approximately HKD 10.11 million was recorded in the same period last year; (2) the group holds a listed.
BJ HEALTH: PROFIT WARNING
bj health (02389.HK) will hold a board of directors meeting on August 29 to approve the interim performance.
BJ Health (02389.HK) announced on August 2 that the board of directors will hold a meeting on August 29, 2024 to consider and approve the group's interim performance for the six months ending June 30, 2024, and to distribute interim dividends (if any) and handle other matters.
bj health (02389.HK) jointly paid off the loan for 2024.
On August 30, 2023, Beijing Health (02389.HK) provided a loan of 0.5 million Canadian dollars to the borrower. On July 26, 2024, the company further advanced 2024 loans to the borrower, 1121695 BC Ltd, with an annual interest rate of 10% and must be repaid as required according to the shareholder agreement.
No Data